Replies to post #349825 on Amarin Corp Plc (AMRN)

[marjac]

Actually it apparently already happened, and is happening, in the sense that generics are engaging in shenanigans. Whether that happened here with Generic V, is a factual question, that remains to be proven.

https://www.npr.org/sections/health-shots/2019/05/12/722216512/bottle-of-lies-exposes-the-dark-side-of-the-generic-drug-boom

[Number sleven]

Sts, Would you actually be surprised if the FDA had policies based on (non binding guidelines) that defied common sense?
Sleven,

[Gussettville]

It also, however, defies common sense to think that the encapsulation method devised by Amarin was deemed worthy of patent protection but does not confer a competent advantage.

Imagine how long it would have taken the medical community to embrace penicillin or aspirin if they were easily oxidized and rendered inactive during processing?

It is shocking how many doctors don’t understand oxidation as it pertains to omega-3 fatty acids.